Exosomal MiR-203 from Bone Marrow Stem Cells Targets the SOCS3/NF-κB Pathway to Regulate Neuroinflammation in Temporal Lobe Epilepsy

Overview

Journal World J Stem Cells

Publisher Baishideng Publishing Group

Date 2025 Mar 10

PMID 40061262

Authors

Wei Wang

Jian Yin

Affiliations

Soon will be listed here.

Abstract

Background: Epilepsy is a prevalent chronic neurological disorder affecting 50 million individuals globally, with temporal lobe epilepsy (TLE) being the most common form. Despite advances in antiepileptic drug development, over 30% of patients suffer from drug-resistant epilepsy, which can lead to severe cognitive impairments and adverse psychosocial outcomes.

Aim: To explore the role of bone marrow mesenchymal stem cell (BMSC)-derived exosomal miR-203 in the regulation of neuroinflammation in a mouse model of epilepsy, providing a theoretical basis for the development of targeted microRNA delivery therapies for drug-resistant epilepsy.

Methods: Adult male C57BL/6 mice were divided into a control group and a TLE model of 30 mice each, and the TLE model group was established by injecting kainic acid. BMSCs were isolated from the mice, and exosomes were purified using ultracentrifugation. Exosomal miR-203 was identified and characterized using high-throughput sequencing and quantitative reverse-transcription polymerase chain reaction. The uptake of exosomes by hippocampal neurons and the subsequent effects on neuroinflammatory markers were assessed using cell culture models.

Results: Exosomal miR-203 exhibited a significant upregulation in BMSCs derived from epileptic mice. investigations demonstrated the efficient internalization of these exosomes by hippocampal neurons, resulting in downregulation of suppressor of cytokine signaling 3 expression and activation of the nuclear factor kappaB pathway, ultimately leading to enhanced secretion of pro-inflammatory cytokines.

Conclusion: Our study identifies exosomal miR-203 as a key regulator of neuroinflammation in a mouse model of epilepsy. The findings suggest that targeting miR-203 may offer a novel therapeutic strategy for epilepsy by modulating the suppression of cytokine signaling 3/nuclear factor kappaB pathway, thus providing a potential avenue for the development of cell-free therapeutics.

References

Bohosova J, Vajcner J, Jabandziev P, Oslejskova H, Slaby O, Aulicka S . MicroRNAs in the development of resistance to antiseizure drugs and their potential as biomarkers in pharmacoresistant epilepsy. Epilepsia. 2021; 62(11):2573-2588. DOI: 10.1111/epi.17063. View

Broekman M, Maas S, Abels E, Mempel T, Krichevsky A, Breakefield X . Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol. 2018; 14(8):482-495. PMC: 6425928. DOI: 10.1038/s41582-018-0025-8. View

Liu C, Zhao X, Wang Q, Du T, Zhang M, Wang H . Astrocyte-derived SerpinA3N promotes neuroinflammation and epileptic seizures by activating the NF-κB signaling pathway in mice with temporal lobe epilepsy. J Neuroinflammation. 2023; 20(1):161. PMC: 10329806. DOI: 10.1186/s12974-023-02840-8. View

Pusic A, Pusic K, Clayton B, Kraig R . IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination. J Neuroimmunol. 2013; 266(1-2):12-23. PMC: 3920591. DOI: 10.1016/j.jneuroim.2013.10.014. View

Karakis I . Focal Cortical Dysplasias: New Advances for Curing Epilepsy. J Clin Neurophysiol. 2024; 40(3):e15-e16. DOI: 10.1097/WNP.0000000000000984. View

Wang J, Zhao J . MicroRNA Dysregulation in Epilepsy: From Pathogenetic Involvement to Diagnostic Biomarker and Therapeutic Agent Development. Front Mol Neurosci. 2021; 14:650372. PMC: 7994516. DOI: 10.3389/fnmol.2021.650372. View

Liu H, Zhang Y, Liu Z, Qi H, Zheng X, Qi L . MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3. Eur Rev Med Pharmacol Sci. 2020; 24(15):7914. DOI: 10.26355/eurrev_202008_22448. View

Dixit A, Tripathi M, Chandra P, Banerjee J . Molecular biomarkers in drug-resistant epilepsy: Facts & possibilities. Int J Surg. 2015; 36(Pt B):483-491. DOI: 10.1016/j.ijsu.2015.08.029. View

Moffatt C, Lamont R . Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect Immun. 2011; 79(7):2632-7. PMC: 3191996. DOI: 10.1128/IAI.00082-11. View

10.

Xian P, Hei Y, Wang R, Wang T, Yang J, Li J . Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019; 9(20):5956-5975. PMC: 6735367. DOI: 10.7150/thno.33872. View

11.

Wang Z, Wen Z, Xu H, Zhang Y, Zhang Y . Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications. Front Mol Neurosci. 2022; 15:1004221. PMC: 9681831. DOI: 10.3389/fnmol.2022.1004221. View

12.

Wang J, Tan L, Tan L, Tian Y, Ma J, Tan C . Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy. Sci Rep. 2015; 5:10201. PMC: 4435024. DOI: 10.1038/srep10201. View

13.

Tamula G, Katyal R, Beniczky S, Nascimento F . Focal cortical dysplasias: New advances for curing epilepsy. Epileptic Disord. 2023; 25(2):284. DOI: 10.1002/epd2.20013. View

14.

Navarro A, Pairet S, Alvarez-Larran A, Pons A, Ferrer G, Longaron R . miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia. Blood Cancer J. 2016; 6:e406. PMC: 4817095. DOI: 10.1038/bcj.2016.10. View

15.

Vezzani A, French J, Bartfai T, Baram T . The role of inflammation in epilepsy. Nat Rev Neurol. 2010; 7(1):31-40. PMC: 3378051. DOI: 10.1038/nrneurol.2010.178. View

16.

Terstappen G, Meyer A, Bell R, Zhang W . Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021; 20(5):362-383. DOI: 10.1038/s41573-021-00139-y. View

17.

Wang Y, Niu H, Li L, Han J, Liu Z, Chu M . Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis. J Nanobiotechnology. 2023; 21(1):109. PMC: 10041751. DOI: 10.1186/s12951-023-01862-x. View

18.

Lin X, Chen H, Zhan X . MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3. Eur Rev Med Pharmacol Sci. 2019; 23(16):6906-6913. DOI: 10.26355/eurrev_201908_18730. View

19.

Sawoo R, Bishayi B . TLR4/TNFR1 blockade suppresses STAT1/STAT3 expression and increases SOCS3 expression in modulation of LPS-induced macrophage responses. Immunobiology. 2024; 229(5):152840. DOI: 10.1016/j.imbio.2024.152840. View

20.

Moshe S, Perucca E, Ryvlin P, Tomson T . Epilepsy: new advances. Lancet. 2014; 385(9971):884-98. DOI: 10.1016/S0140-6736(14)60456-6. View